Vertex Pharmaceuticals Stock Forecast - Relative Strength Index
| VRTX Stock | USD 468.41 1.06 0.23% |
Vertex Stock outlook is based on your current time horizon.
At this time, The RSI of Vertex Pharmaceuticals' share price is at 57. This entails that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Vertex Pharmaceuticals, making its price go up or down. Momentum 57
Buy Extended
Oversold | Overbought |
Quarterly Earnings Growth 0.047 | EPS Estimate Next Quarter 4.8961 | EPS Estimate Current Year 18.4284 | EPS Estimate Next Year 20.2079 | Wall Street Target Price 506.24 |
Using Vertex Pharmaceuticals hype-based prediction, you can estimate the value of Vertex Pharmaceuticals from the perspective of Vertex Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Vertex Pharmaceuticals using Vertex Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Vertex using crowd psychology based on the activity and movement of Vertex Pharmaceuticals' stock price.
Vertex Pharmaceuticals Short Interest
An investor who is long Vertex Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Vertex Pharmaceuticals and may potentially protect profits, hedge Vertex Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 436.8682 | Short Percent 0.0224 | Short Ratio 3.84 | Shares Short Prior Month 4.3 M | 50 Day MA 447.9564 |
Vertex Relative Strength Index
Vertex Pharmaceuticals Hype to Price Pattern
Investor biases related to Vertex Pharmaceuticals' public news can be used to forecast risks associated with an investment in Vertex. The trend in average sentiment can be used to explain how an investor holding Vertex can time the market purely based on public headlines and social activities around Vertex Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Vertex Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Vertex Pharmaceuticals.
Vertex Pharmaceuticals Implied Volatility | 0.38 |
Vertex Pharmaceuticals' implied volatility exposes the market's sentiment of Vertex Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Vertex Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Vertex Pharmaceuticals stock will not fluctuate a lot when Vertex Pharmaceuticals' options are near their expiration.
Vertex Pharmaceuticals after-hype prediction price | USD 468.41 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Vertex Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Vertex contract
Based on the Rule 16, the options market is currently suggesting that Vertex Pharmaceuticals will have an average daily up or down price movement of about 0.0238% per day over the life of the 2026-04-17 option contract. With Vertex Pharmaceuticals trading at USD 468.41, that is roughly USD 0.11 . If you think that the market is fully incorporating Vertex Pharmaceuticals' daily price movement you should consider acquiring Vertex Pharmaceuticals options at the current volatility level of 0.38%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Vertex Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Vertex Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Vertex Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Vertex Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Vertex Pharmaceuticals' open interest, investors have to compare it to Vertex Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Vertex Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Vertex. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Vertex Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Vertex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vertex using various technical indicators. When you analyze Vertex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 57.09 | 57.09 |
| Check Vertex Pharmaceuticals Volatility | Backtest Vertex Pharmaceuticals | Information Ratio |
Vertex Pharmaceuticals Trading Date Momentum
| On January 26 2026 Vertex Pharmaceuticals was traded for 468.41 at the closing time. The top price for the day was 470.34 and the lowest listed price was 462.74 . There was no trading activity during the period 0.0. Lack of trading volume on January 26, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.68% . |
| Compare Vertex Pharmaceuticals to competition |
Other Forecasting Options for Vertex Pharmaceuticals
For every potential investor in Vertex, whether a beginner or expert, Vertex Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vertex Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vertex. Basic forecasting techniques help filter out the noise by identifying Vertex Pharmaceuticals' price trends.Vertex Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vertex Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Vertex Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Vertex Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Vertex Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Vertex Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vertex Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Vertex Pharmaceuticals stock market strength indicators, traders can identify Vertex Pharmaceuticals entry and exit signals to maximize returns.
Vertex Pharmaceuticals Risk Indicators
The analysis of Vertex Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vertex Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vertex stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.22 | |||
| Semi Deviation | 1.2 | |||
| Standard Deviation | 1.72 | |||
| Variance | 2.96 | |||
| Downside Variance | 1.89 | |||
| Semi Variance | 1.44 | |||
| Expected Short fall | (1.39) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Vertex Pharmaceuticals
The number of cover stories for Vertex Pharmaceuticals depends on current market conditions and Vertex Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vertex Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vertex Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Vertex Pharmaceuticals Short Properties
Vertex Pharmaceuticals' future price predictability will typically decrease when Vertex Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vertex Pharmaceuticals often depends not only on the future outlook of the potential Vertex Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vertex Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 257.9 M | |
| Cash And Short Term Investments | 6.1 B |
Additional Tools for Vertex Stock Analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.